Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jochen Utikal

Showing results (141-150 of 276) with videos related to

Pageof 28
Sort By:
International Journal of Cancer|March 16, 2019
Characterization of six Merkel cell polyomavirus-positive Merkel cell carcinoma cell lines: Integration pattern suggest that large T antigen truncating events occur before or during integrationDavid Schrama, Eva-Maria Sarosi, Christian Adam, et al.
Oncoimmunology|June 15, 2018
Optimized dendritic cell vaccination induces potent CD8 T cell responses and anti-tumor effects in transgenic mouse melanoma modelsMareike Grees, Adi Sharbi-Yunger, Christos Evangelou, et al.
International Journal of Cancer|April 10, 2021
FOXD1 promotes dedifferentiation and targeted therapy resistance in melanoma by regulating the expression of connective tissue growth factorQian Sun, Daniel Novak, Laura Hüser, et al.
Cell Death & Disease|October 9, 2019
ADP secreted by dying melanoma cells mediates chemotaxis and chemokine secretion of macrophages via the purinergic receptor P2Y12Loreen Kloss, Claudia Dollt, Kai Schledzewski, et al.
Cell Stem Cell|March 29, 2008
Directly reprogrammed fibroblasts show global epigenetic remodeling and widespread tissue contributionNimet Maherali, Rupa Sridharan, Wei Xie, et al.
Stem Cell Reports|April 11, 2017
Melanoma-Derived iPCCs Show Differential Tumorigenicity and Therapy ResponseMathias Bernhardt, Daniel Novak, Yassen Assenov, et al.
Journal for Immunotherapy of Cancer|March 18, 2022
STAT3 inhibitor Napabucasin abrogates MDSC immunosuppressive capacity and prolongs survival of melanoma-bearing miceRebekka Bitsch, Annina Kurzay, Feyza Özbay Kurt, et al.
Cancers|December 17, 2020
HER3-Receptor-Mediated STAT3 Activation Plays a Central Role in Adaptive Resistance toward Vemurafenib in MelanomaLaura Hüser, Marianthi-Maria Kokkaleniou, Karol Granados, et al.
Scientific Reports|July 20, 2021
TRPV1 activation and internalization is part of the LPS-induced inflammation in human iPSC-derived cardiomyocytesKatherine Sattler, Ibrahim El-Battrawy, Lukas Cyganek, et al.
European Journal of Medicinal Chemistry|May 30, 2023
Development of a next-generation endogenous OCT4 inducer and its anti-aging effect in vivoHan Kang, Sebastian Hasselbeck, Katerina Taškova, et al.
Pageof 28

Showing results (141-150 of 276) with videos related to

Sort By:
Pageof 28
International Journal of Cancer|March 16, 2019
Characterization of six Merkel cell polyomavirus-positive Merkel cell carcinoma cell lines: Integration pattern suggest that large T antigen truncating events occur before or during integrationDavid Schrama, Eva-Maria Sarosi, Christian Adam, et al.
Oncoimmunology|June 15, 2018
Optimized dendritic cell vaccination induces potent CD8 T cell responses and anti-tumor effects in transgenic mouse melanoma modelsMareike Grees, Adi Sharbi-Yunger, Christos Evangelou, et al.
International Journal of Cancer|April 10, 2021
FOXD1 promotes dedifferentiation and targeted therapy resistance in melanoma by regulating the expression of connective tissue growth factorQian Sun, Daniel Novak, Laura Hüser, et al.
Cell Death & Disease|October 9, 2019
ADP secreted by dying melanoma cells mediates chemotaxis and chemokine secretion of macrophages via the purinergic receptor P2Y12Loreen Kloss, Claudia Dollt, Kai Schledzewski, et al.
Cell Stem Cell|March 29, 2008
Directly reprogrammed fibroblasts show global epigenetic remodeling and widespread tissue contributionNimet Maherali, Rupa Sridharan, Wei Xie, et al.
Stem Cell Reports|April 11, 2017
Melanoma-Derived iPCCs Show Differential Tumorigenicity and Therapy ResponseMathias Bernhardt, Daniel Novak, Yassen Assenov, et al.
Journal for Immunotherapy of Cancer|March 18, 2022
STAT3 inhibitor Napabucasin abrogates MDSC immunosuppressive capacity and prolongs survival of melanoma-bearing miceRebekka Bitsch, Annina Kurzay, Feyza Özbay Kurt, et al.
Cancers|December 17, 2020
HER3-Receptor-Mediated STAT3 Activation Plays a Central Role in Adaptive Resistance toward Vemurafenib in MelanomaLaura Hüser, Marianthi-Maria Kokkaleniou, Karol Granados, et al.
Scientific Reports|July 20, 2021
TRPV1 activation and internalization is part of the LPS-induced inflammation in human iPSC-derived cardiomyocytesKatherine Sattler, Ibrahim El-Battrawy, Lukas Cyganek, et al.
European Journal of Medicinal Chemistry|May 30, 2023
Development of a next-generation endogenous OCT4 inducer and its anti-aging effect in vivoHan Kang, Sebastian Hasselbeck, Katerina Taškova, et al.
Pageof 28